Raba Thapa*

Associate Professor of Ophthalmology (NAMS), Vitreo-retina specialist, Tilganga Institute of Ophthalmology, Kathmandu, Nepal

*Corresponding Author: Raba Thapa, Associate Professor of Ophthalmology (NAMS), Vitreo-retina specialist, Tilganga Institute of Ophthalmology, Kathmandu, Nepal.

Received: May 23, 2021; Published: August 18, 2021

Diabetes Mellitus (DM) is emerging as a major public health problem globally. DM has been the leading cause of mortality and various morbidities including blindness both in high income and in low and middle-income countries. In recent report of International Diabetes Federation (IDF), 463 million adults aged 20 - 79 years worldwide (9.3% of all adults in this age group) have diabetes in 2019 and this number is projected to be 478 million by 2030 and 700 million by 2045 globally [1]. Almost four fifth (79.4%) of people with diabetes live in low and middle-income countries. The burden of diabetes has overwhelmed many healthcare systems, especially those of low and middle-income countries [1].

References

1. International Diabetes Federation. Diabetes Atlas”. 9^th Brussels: IDF (2019).
2. World Health Organization. “Prevention of blindness from diabetes mellitus: report of a WHO consultation in Geneva”. Geneva: World Health Organization (2006).
3. Leasher JL., et al. “Vision Loss Expert Group of the global burden of disease study. Global estimates on the number of people blind or visually impaired by diabetic retinopathy: A Meta-analysis from 1990 to 2010”. Diabetes Care9 (2016): 1643-1649.
4. Shaw JE., et al. “Global estimates of the prevalence of diabetes for 2010 and 2030”. Diabetes Research and Clinical Practice1 (2010): 4-14.
5. Yau JW., et al. “Meta-analysis for eye disease (META-EYE) study group. Global prevalence and major risk factors of diabetic retinopathy”. Diabetes Care3 (2012): 556-564.
6. Lee R., et al. “Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss”. Eye Vis1 (2015): 17.
7. Wong TY and Sabanayagama C. “Strategies to Tackle the Global Burden of Diabetic Retinopathy: From epidemiology to artificial intelligence”. Ophthalmologica 243 (2020): 9-20.
8. Takkar B., et al. “Development of Diabetic retinopathy screening guidelines in South-East Asia region using the context, challenges, and future technology”. Seminars in Ophthalmology (2021): 1-8.
9. Thapa R., et al. “Prevalence and risk factors of diabetic retinopathy among an elderly population with diabetes in Nepal: The Bhaktapur Retina Study”. Clinical Ophthalmology 12 (2018): 561-568.
10. Mishra SK., et al. “The prevalence of diabetic retinopathy among known diabetic population in Nepal”. Kathmandu University Medical Journal2 (2016): 134-139.
11. Paudyal G., et al. “Prevalence of diabetic retinopathy following a community screening for diabetes”. Nepal Medical College Journal 3 (2008): 160-163.
12. Shrestha MK., et al. “Prevalence of and factors associated with diabetic retinopathy among diabetics in Nepal: a hospital based study”. Nepal medical College Journal 4 (2007): 225-229.
13. Thapa R., et al. “Prevalence, risk factors and awareness of diabetic retinopathy among admitted diabetic patients at a tertiary level hospital in Kathmandu”. Nepalese Journal of Ophthalmology 11 (2014): 24-30.
14. Shrestha S., et al. “Retinopathy in a diabetic population”. Kathmandu University Medical Journal 2 (2007): 204-209.
15. Raymond NT., et al. “UK Asian Diabetes Study Retinopathy Study Group. Higher prevalence of retinopathy in diabetic patients of South Asian ethnicity compared with white Europeans in the community: a cross-sectional study”. Diabetes Care 3 (2009): 410-415.
16. Tan GS., et al. “Ethnic Differences in the Prevalence and Risk Factors of Diabetic Retinopathy: The Singapore Epidemiology of Eye Diseases Study”. Ophthalmology4 (2018): 529-536.
17. Zhang X., et al. “Prevalence of diabetic retinopathy in the United States, 2005- 2008”. JAMA: The Journal of the American Medical Association6 (2010): 649-656.
18. Klein R., et al. “The Wisconsin Epidemiologic Study of Diabetic Retinopathy. X. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is 30 years or more”. Archives of Ophthalmology2 (1989): 244-249.
19. Klein R., et al. “The Wisconsin Epidemiologic Study of Diabetic Retinopathy. IX. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is less than 30 years”. Archives of Ophthalmology2 (1989): 237-243.
20. Ruta LM., et al. “Prevalence of diabetic retinopathy in type 2 diabetes in developing and developed countries”. Diabetic Medicine 30 (2013): 387-398.
21. Thomas RL., et al. “IDF Diabetes Atlas: A review of studies utilizing retinal photography on the global prevalence of diabetes related retinopathy between 2015 and 2018”. Diabetes Research and Clinical Practice (2019): 157.

Citation

Citation: Raba Thapa. “Diabetic Retinopathy Prevalence in High Income and Low Middle-Income Countries".Acta Scientific Ophthalmology 4.9 (2021): 39-41.

Copyright

Copyright: © 2021 Raba Thapa. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.